226 related articles for article (PubMed ID: 28719811)
41. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
Stovall M; Smith SA; Langholz BM; Boice JD; Shore RE; Andersson M; Buchholz TA; Capanu M; Bernstein L; Lynch CF; Malone KE; Anton-Culver H; Haile RW; Rosenstein BS; Reiner AS; Thomas DC; Bernstein JL;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1021-30. PubMed ID: 18556141
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
43. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract][Full Text] [Related]
44. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
45. Increased risk of second cancers following breast cancer: role of the initial treatment.
Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Lê MG
Breast Cancer Res Treat; 2000 Jun; 61(3):183-95. PubMed ID: 10965995
[TBL] [Abstract][Full Text] [Related]
46. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
47. Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer.
Ramsey SD; Zeliadt SB; Richardson LC; Pollack LA; Linden H; Blough DK; Cheteri MK; Tock L; Nagy K; Anderson N
Breast J; 2010; 16(1):20-7. PubMed ID: 19929888
[TBL] [Abstract][Full Text] [Related]
48. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.
Mery CM; George S; Bertagnolli MM; Raut CP
Cancer; 2009 Sep; 115(18):4055-63. PubMed ID: 19526590
[TBL] [Abstract][Full Text] [Related]
49. Increased risk of colon cancer after external radiation therapy for prostate cancer.
Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
[TBL] [Abstract][Full Text] [Related]
50. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.
Basu SK; Schwartz C; Fisher SG; Hudson MM; Tarbell N; Muhs A; Marcus KJ; Mendenhall N; Mauch P; Kun LE; Constine LS
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):34-40. PubMed ID: 18722264
[TBL] [Abstract][Full Text] [Related]
51. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
52. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
53. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
54. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
55. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
56. Radiation-induced second malignancies.
Mahmood S; Vu K; Tai P; Joseph K; Koul R; Dubey A; Yu E
Anticancer Res; 2015 Apr; 35(4):2431-4. PubMed ID: 25862910
[TBL] [Abstract][Full Text] [Related]
57. Risk of second primary lung cancer in women after radiotherapy for breast cancer.
Grantzau T; Thomsen MS; Væth M; Overgaard J
Radiother Oncol; 2014 Jun; 111(3):366-73. PubMed ID: 24909095
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Drooger J; Akdeniz D; Pignol JP; Koppert LB; McCool D; Seynaeve CM; Hooning MJ; Jager A
Breast Cancer Res Treat; 2015 Nov; 154(1):171-80. PubMed ID: 26467044
[TBL] [Abstract][Full Text] [Related]
59. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
Brenner DJ; Curtis RE; Hall EJ; Ron E
Cancer; 2000 Jan; 88(2):398-406. PubMed ID: 10640974
[TBL] [Abstract][Full Text] [Related]
60. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
